Ameritas Advisory Services’s Moderna MRNA Stock Holding History

Ameritas Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77.7K	Buy	+1,110	New	+$57.4K	﹤0.01%	1197
2025 Q4	–	Sell	-375	Closed	-$9.69K	–	1677
2025 Q3	$9.69K	Sell	375 -304	-45%	-$8.48K	﹤0.01%	1671
2025 Q2	$18.7K	Buy	+679	New	+$17.9K	﹤0.01%	1770
2023 Q2	–	Sell	-1,142	Closed	-$167K	–	1790
2023 Q1	$167K	Sell	1,142 -915	-44%	-$151K	0.01%	823
2022 Q4	$369K	Buy	2,057 +332	+19%	+$54.3K	0.02%	634
2022 Q3	$204K	Sell	1,725 -484	-22%	-$73.4K	0.01%	708
2022 Q2	$316K	Buy	2,209 +327	+17%	+$46.7K	0.02%	600
2022 Q1	$324K	Sell	1,882 -91	-5%	-$15.3K	0.01%	641
2021 Q4	$501K	Buy	+1,973	New	+$577K	0.02%	511

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Ameritas Advisory Services's MRNA Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in Moderna (MRNA) in Q2 2026: 1,110 shares worth $77.7K. The stake represents ﹤0.01% of the portfolio and ranks #1197 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in MRNA as recently as Q3 2025.

Ameritas Advisory Services first reported a position in MRNA in Q4 2021 and has held it in 9 quarters since. The position peaked at $501K in Q4 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Ameritas Advisory Services held 1,110 shares of Moderna worth $77.7K as of Q2 2026.
Moderna was a new Ameritas Advisory Services position in Q2 2026.
Moderna made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1197 holding.
Ameritas Advisory Services first reported a position in Moderna in Q4 2021 and has held it in 9 quarters since.
Ameritas Advisory Services's Moderna position peaked at $501K in Q4 2021.
783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.